PTPI
Price:
$0.2846
Market Cap:
$2.85M
Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for the treatment of acute Peyronie's disease. The company markets its line of ED products in the form of vacuum erection device products. Petros Pharmaceuticals, Inc. is based in New York, New York.[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2020-12-02
Stock Exchange
NASDAQ
Ticker
PTPI
According to Petros Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 6.20M. This represents a change of 104.73% compared to the average of 3.03M of the last 4 quarters.
The mean historical Enterprise Value of Petros Pharmaceuticals, Inc. over the last ten years is 19.25M. The current 6.20M Enterprise Value has changed 3.12% with respect to the historical average. Over the past ten years (40 quarters), PTPI's Enterprise Value was at its highest in in the December 2020 quarter at 38.68M. The Enterprise Value was at its lowest in in the September 2023 quarter at -5614972.36.
Average
19.25M
Median
15.61M
Minimum
-1992200.03
Maximum
48.39M
Discovering the peaks and valleys of Petros Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 77.90%
Maximum Annual Enterprise Value = 48.39M
Minimum Annual Increase = -138.78%
Minimum Annual Enterprise Value = -1992200.03
Year | Enterprise Value | Change |
---|---|---|
2023 | -1992200.03 | -138.78% |
2022 | 5.14M | -59.92% |
2021 | 12.82M | -60.85% |
2020 | 32.75M | 77.90% |
2019 | 18.41M | -61.96% |
The current Enterprise Value of Petros Pharmaceuticals, Inc. (PTPI) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
5.32M
5-year avg
13.42M
10-year avg
19.25M
Petros Pharmaceuticals, Inc.’s Enterprise Value is greater than Sunshine Biopharma, Inc. (-5651124.00), greater than Guardion Health Sciences, Inc. (-10475955.00), greater than Sonoma Pharmaceuticals, Inc. (-245024.00), less than Alpha Teknova, Inc. (433.84M), greater than Evoke Pharma, Inc. (1.03M), less than Cumberland Pharmaceuticals Inc. (35.61M), less than Agile Therapeutics, Inc. (7.87M), greater than PainReform Ltd. (-89853.00), less than Mallinckrodt plc (2.67B), less than Lifecore Biomedical, Inc. (390.24M), greater than Lucy Scientific Discovery Inc. (2.06M), less than Alimera Sciences, Inc. (362.58M), greater than Adamis Pharmaceuticals Corporation (-6593458674.00), less than China Pharma Holdings, Inc. (6.76M), less than Halo Collective Inc. (16.67M), greater than China SXT Pharmaceuticals, Inc. (-8217730.00), greater than Akanda Corp. (-3317592.00), greater than GelStat Corporation (775.53K), greater than Shuttle Pharmaceuticals Holdings, Inc. (3.03M),
Company | Enterprise Value | Market cap |
---|---|---|
-5651124.00 | $6.00M | |
-10475955.00 | $4.35M | |
-245024.00 | $3.59M | |
433.84M | $409.40M | |
1.03M | $7.37M | |
35.61M | $31.60M | |
7.87M | $10.43M | |
-89853.00 | $2.63M | |
2.67B | $4.52M | |
390.24M | $258.89M | |
2.06M | $906.91K | |
362.58M | $301.29M | |
-6593458674.00 | $7.25M | |
6.76M | $3.47M | |
16.67M | $15.08K | |
-8217730.00 | $1.21M | |
-3317592.00 | $2.34M | |
775.53K | $185.39K | |
3.03M | $2.62M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Petros Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Petros Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Petros Pharmaceuticals, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Petros Pharmaceuticals, Inc. (PTPI)?
What is the 3-year average Enterprise Value for Petros Pharmaceuticals, Inc. (PTPI)?
What is the 5-year average Enterprise Value for Petros Pharmaceuticals, Inc. (PTPI)?
How does the current Enterprise Value for Petros Pharmaceuticals, Inc. (PTPI) compare to its historical average?